RecruitingNot ApplicableNCT06312046

Motor-cognitive Performance in People With Multiple Sclerosis

Motor-cognitive Performance in People With Multiple Sclerosis - Brain Activity and Effects of Balance Exercise


Sponsor

Karolinska Institutet

Enrollment

90 participants

Start Date

Feb 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Having a neurological disease such as multiple sclerosis (MS) leads to difficulties in balance and gait with or without concurrent performance of cognitive tasks, hindering activity performance and influencing the possibilities for an independent lifestyle. The investigators have adapted a previously developed balance training program to a highly challenging program specifically directed to MS (HiBalance-MS). This program was recently tested and found feasible in a pilot study. The investigators will now perform a randomized controlled trial in people with MS, in order to determine the effects of the program. The hypothesis is that progressively challenging balance exercise programs that are specific to the balance control domains affected by MS will be effective to improve balance control, walking, motor-cognitive performance, activity performance and health related quality of life.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria5

  • an MS diagnosis according to McDonald criteria;
  • an overall MS-disability score from 2.0 to 5.5 according to the Expanded Disability Status Scale;
  • ability to walk 100 m without aid;
  • a maximum score of 24 in the Mini-BESTest (i.e., \< 25 points)
  • to 65 years of age

Exclusion Criteria3

  • cognitive impairment as indicated by a score \<21 in the Montreal Cognitive Assessment;
  • presence of other conditions that would substantially influence balance;
  • an MS relapse or change of disease-modifying treatment within the past 8 weeks

Interventions

OTHERHiBalance-MS

See arm description for intervention group.


Locations(1)

Karolinska Institutet

Stockholm, Stockholm County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06312046


Related Trials